These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 25471116

  • 1. DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure.
    Koibuchi N, Hasegawa Y, Katayama T, Toyama K, Uekawa K, Sueta D, Kusaka H, Ma M, Nakagawa T, Lin B, Kim-Mitsuyama S.
    Cardiovasc Diabetol; 2014 Nov 29; 13():157. PubMed ID: 25471116
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome.
    Hattori T, Murase T, Takatsu M, Nagasawa K, Matsuura N, Watanabe S, Murohara T, Nagata K.
    J Am Heart Assoc; 2014 Dec 02; 3(6):e001312. PubMed ID: 25468654
    [Abstract] [Full Text] [Related]

  • 8. Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.
    Kröller-Schön S, Knorr M, Hausding M, Oelze M, Schuff A, Schell R, Sudowe S, Scholz A, Daub S, Karbach S, Kossmann S, Gori T, Wenzel P, Schulz E, Grabbe S, Klein T, Münzel T, Daiber A.
    Cardiovasc Res; 2012 Oct 01; 96(1):140-9. PubMed ID: 22843705
    [Abstract] [Full Text] [Related]

  • 9. Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury.
    Terawaki Y, Nomiyama T, Kawanami T, Hamaguchi Y, Takahashi H, Tanaka T, Murase K, Nagaishi R, Tanabe M, Yanase T.
    Cardiovasc Diabetol; 2014 Nov 19; 13():154. PubMed ID: 25407968
    [Abstract] [Full Text] [Related]

  • 10. DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice.
    Ma M, Hasegawa Y, Koibuchi N, Toyama K, Uekawa K, Nakagawa T, Lin B, Kim-Mitsuyama S.
    Cardiovasc Diabetol; 2015 May 20; 14():54. PubMed ID: 25986579
    [Abstract] [Full Text] [Related]

  • 11. Puerarin Improves Vascular Insulin Resistance and Cardiovascular Remodeling in Salt-Sensitive Hypertension.
    Tan C, Wang A, Liu C, Li Y, Shi Y, Zhou MS.
    Am J Chin Med; 2017 May 20; 45(6):1169-1184. PubMed ID: 28830209
    [Abstract] [Full Text] [Related]

  • 12. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
    Kanasaki K, Shi S, Kanasaki M, He J, Nagai T, Nakamura Y, Ishigaki Y, Kitada M, Srivastava SP, Koya D.
    Diabetes; 2014 Jun 20; 63(6):2120-31. PubMed ID: 24574044
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.
    Yamaguchi T, Watanabe A, Tanaka M, Shiota M, Osada-Oka M, Sano S, Yoshiyama M, Miura K, Kitajima S, Matsunaga S, Tomita S, Iwao H, Izumi Y.
    J Pharmacol Sci; 2019 Feb 20; 139(2):112-119. PubMed ID: 30638989
    [Abstract] [Full Text] [Related]

  • 15. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M.
    Am J Hypertens; 2007 Oct 20; 20(10):1119-24. PubMed ID: 17903697
    [Abstract] [Full Text] [Related]

  • 16. A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
    Nakajima Y, Ito S, Asakura M, Min KD, Fu HY, Imazu M, Hitsumoto T, Takahama H, Shindo K, Fukuda H, Yamazaki S, Asanuma H, Kitakaze M.
    J Mol Cell Cardiol; 2019 Apr 20; 129():257-265. PubMed ID: 30880253
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A, Finckenberg P, Korpi A, Loytainen M, Martonen E, Levijoki J, Mervaala E.
    J Physiol Pharmacol; 2011 Jun 20; 62(3):275-85. PubMed ID: 21893687
    [Abstract] [Full Text] [Related]

  • 18. D-allose, an all-cis aldo-hexose, suppresses development of salt-induced hypertension in Dahl rats.
    Kimura S, Zhang GX, Nishiyama A, Nagai Y, Nakagawa T, Miyanaka H, Fujisawa Y, Miyatake A, Nagai T, Tokuda M, Abe Y.
    J Hypertens; 2005 Oct 20; 23(10):1887-94. PubMed ID: 16148613
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.